Female sexual desire drug approved

Addyi-Flibanserin-FDA-approval_Credit-Sprout-Pharmaceuticals_300tb

Source: Sprout Pharmaceuticals

Concerns raised over efficacy, side effects and use of advocacy campaigning to influence regulatory decisions